This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Ventfort
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict WATCH-LIST LOW
Same Khavinson-class evidence concerns — Russian preclinical + small clinical series only, no Western replication. The vascular-endothelium target is theoretically interesting for longevity but the oral tripeptide is destroyed by gut peptidases in any meaningful percentage. Even the injectable form has uncharacterized PK. For Dylan with intact endothelium, no current case.
▸ Verdict change log
- 2026-06-05 — Initial verdict WATCH-LIST. (stub)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.